Healthcare provider profile · identity verified

David T. Wolfe, DO

Family Practice · ANAHEIM, CA · NPI 1316018229

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	629	205
Amlodipine Besylate	Amlodipine Besylate	311	112
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	296	51
Losartan Potassium	Losartan Potassium	281	92
Rosuvastatin Calcium	Rosuvastatin Calcium	276	99
Lisinopril	Lisinopril	208	73
Simvastatin	Simvastatin	176	59
Levothyroxine Sodium	Levothyroxine Sodium	165	48
Tamsulosin Hcl	Tamsulosin Hcl	158	57
Omeprazole	Omeprazole	145	60
Glipizide	Glipizide	140	51
Metoprolol Tartrate	Metoprolol Tartrate	133	45
Potassium Chloride	Potassium Chloride	132	51
Albuterol Sulfate Hfa	Albuterol Sulfate	126	56
Metformin Hcl Er	Metformin Hcl	124	50
Atenolol	Atenolol	123	37
Gabapentin	Gabapentin	118	51
Furosemide	Furosemide	116	40
Metformin Hcl	Metformin Hcl	116	40
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	92	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	89	31
Ezetimibe	Ezetimibe	88	33
Azelastine Hcl	Azelastine Hcl	78	44
Morphine Sulfate Er	Morphine Sulfate	78	suppressed
Jardiance	Empagliflozin	76	26
Pantoprazole Sodium	Pantoprazole Sodium	75	31
Finasteride	Finasteride	73	22
Alendronate Sodium	Alendronate Sodium	72	31
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	70	23
Prednisone	Prednisone	70	48
Trazodone Hcl	Trazodone Hcl	68	26
Allopurinol	Allopurinol	66	21
Humulin N Kwikpen	Insulin Nph Human Isophane	65	19
Ozempic	Semaglutide	65	13
Bisoprolol Fumarate	Bisoprolol Fumarate	64	21
Eliquis	Apixaban	64	16
Meloxicam	Meloxicam	57	25
Hydrochlorothiazide	Hydrochlorothiazide	56	19
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	51	47
Nifedipine Er	Nifedipine	51	20
Terazosin Hcl	Terazosin Hcl	51	17
Triamcinolone Acetonide	Triamcinolone Acetonide	50	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	48	16
Zolpidem Tartrate	Zolpidem Tartrate	48	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	47	18
Doxycycline Monohydrate	Doxycycline Monohydrate	45	40
Famotidine	Famotidine	44	26
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	43	43
Humulin N	Insulin Nph Human Isophane	41	14
Spiriva Respimat	Tiotropium Bromide	39	11
Pioglitazone Hcl	Pioglitazone Hcl	38	12
Alvesco	Ciclesonide	37	20
Ondansetron Odt	Ondansetron	37	16
Azithromycin	Azithromycin	36	34
Fluoxetine Hcl	Fluoxetine Hcl	36	13
Clopidogrel	Clopidogrel Bisulfate	35	13
Hydralazine Hcl	Hydralazine Hcl	35	14
Ibuprofen	Ibuprofen	35	19
Temazepam	Temazepam	34	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	33	16
Buspirone Hcl	Buspirone Hcl	32	12
Lactulose	Lactulose	32	suppressed
Duloxetine Hcl	Duloxetine Hcl	30	15
Hydrocortisone	Hydrocortisone	30	17
Acetaminophen-Codeine	Acetaminophen With Codeine	29	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	29	11
Mirtazapine	Mirtazapine	29	12
Alprazolam	Alprazolam	28	suppressed
Cephalexin	Cephalexin	28	24
Glimepiride	Glimepiride	28	11
Sertraline Hcl	Sertraline Hcl	28	11
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	28	12
Wixela Inhub	Fluticasone Propion/Salmeterol	28	15
Amoxicillin	Amoxicillin	27	20
Carvedilol	Carvedilol	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	11
Morphine Sulfate	Morphine Sulfate	24	suppressed
Humulin R	Insulin Regular, Human	22	suppressed
Naproxen	Naproxen	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	21	20
Digoxin	Digoxin	21	suppressed
Propranolol Hcl	Propranolol Hcl	21	suppressed
Clonazepam	Clonazepam	20	suppressed
Victoza 2-Pak	Liraglutide	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Montelukast Sodium	Montelukast Sodium	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Cefuroxime	Cefuroxime Axetil	18	18
Colchicine	Colchicine	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Lorazepam	Lorazepam	18	11
Lovastatin	Lovastatin	18	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	18	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	17
Fluticasone Propionate	Fluticasone Propionate	17	suppressed
Metoprolol Succinate	Metoprolol Succinate	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	15	15
Estradiol	Estradiol	15	suppressed
Memantine Hcl	Memantine Hcl	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Cartia Xt	Diltiazem Hcl	14	suppressed
Liraglutide	Liraglutide	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Ofloxacin	Ofloxacin	13	13
Testosterone	Testosterone	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	12	suppressed
Fluorouracil	Fluorouracil	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Naratriptan Hcl	Naratriptan Hcl	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error